Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product

These study results should facilitate the use of SA 14-14-2 JE vaccine as a routine component of immunization programs in Asian countries.